About US
Contact us
-
Kyowa Kirin to expand manufacturing footprint with $530M biologics plant in North CarolinaWith board approval in hand, Kyowa Kirin can move forward with plans to establisha $530 million manufacturing site in North Carolina. Construction on the state-of-the-art, 171,700-square-foot facilit2024/6/4
-
GSK, attempting to stage Blenrep comeback, bids adieu to combo studies with SpringWorks' OgsiveoDespite the recent approval of SpringWorks Therapeutics’ Ogsiveo, GSK is calling it quits on prior plans to wed the Pfizer spinout’s drug with its withdrawn cancer med Blenrep. SpringWorks on Thursda2024/5/30
-
With 2 planned launches, Boehringer Ingelheim looks to make a name for itself in oncologyWith 25 launches planned through 2030, Boehringer Ingelheim is gearing up for a busy few years. As a part of that, the German drugmaker is looking forward to flexing its oncology muscles with two new2024/5/30
-
GSK exec lauds 'great start' to RSV vaccine uptake as Arexvy nabs label expansion in adults 50-59Thanks to respiratory syncytial virus (RSV) shot Arexvy’s new label expansion into a slightly younger pool of adults, GSK is more confident than ever that its vaccine will be able to conquer the comp2024/5/28
-
After 33 years, Geron finally crosses FDA finish line with blood cancer med RyteloOnce hailed as an anti-aging magic bullet, telomerase has failed to live up to the hype as it wasprofiledin a 1998 Los Angeles Times article: “Could immortality be within grasp? Scientists say yes.”2024/5/28
-
Ex-staffer pleads guilty to scamming Takeda out of $2.3M through fake consulting firmAfter fessing up to wire fraud charges, a former Takeda employee will be preparing for a sentencing hearing rather than walking down the aisle with $2.3 million garnered through a scheme to defraud t2024/5/21
-
BMS chief Boerner says company is still open to deals after spending more than $20B on M&A last yearAs some pharma giants pump the brakes on big M&A deals, Bristol Myers Squibb—hot off a series of rapid-fire acquisitions in 2023—says it still has dealmaking cash to deploy if the right target co2024/5/21
-
UPDATED: Sanders wants to subpoena Novo Nordisk exec to answer questions on Wegovy, Ozempic pricingSen. Bernie Sanders, I-Vermont, is stepping up his attack on Novo Nordisk over the prices the company charges in the U.S. for its wildly popular diabetes and weight loss drugs. Sanders, the chairman2024/5/16
-
Europe taps CSL Seqirus to produce bird flu vaccines for pandemic preparedness effortsRight after signing on to help with bird flu pandemic preparedness efforts in the U.S., CSL Seqirus has agreed to do the same in Europe through a vaccine supply pact. The European Commission’s Health2024/5/16
-
Ahead of UK election, life sciences trade group pushes politicians to boost local industryAs the U.K. braces for a potential government shake-up ahead of its general election next month, the country’s premier biopharma trade organization is throwing down the gauntlet. The Association of t2024/5/14